In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the recent news of a possible cure for sickle cell disease, as well as gene editing therapies and their impact on the laboratory. Their discussion includes:Characteristics of sickle cell disease and current testing and treatment options.Advantages, challenges, and ethical considerations for gene editing tools.How gene therapies may impact the laboratory and the process for testing specimens.How the high cost of innovative therapeutics may accentuate disparities in care.

Ver todos los episodios